Lexeo Therapeutics, Inc. · NASDAQ:LXEO
BlackRock, Inc. reported a 6.70% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 6.70% stake in Lexeo Therapeutics, Inc., 4,885,814 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 4,885,814
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.70% | 4,885,814 |
Source
Related
- Lexeo Therapeutics, Inc.
- BlackRock, Inc.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026